Two Sigma Advisers’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.41M | Buy |
|
|||||
|
2025
Q2 | $1.53M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $264K | Sell |
|
|||||
|
2024
Q1 | $379K | Sell |
|
|||||
|
2023
Q4 | $421K | Sell |
|
|||||
|
2023
Q3 | $507K | Buy |
|
|||||
|
2023
Q2 | $498K | Sell |
|
|||||
|
2023
Q1 | $576K | Sell |
|
|||||
|
2022
Q4 | $477K | Sell |
|
|||||
|
2022
Q3 | $674K | Sell |
|
|||||
|
2022
Q2 | $763K | Sell |
|
|||||
|
2022
Q1 | $1.45M | Sell |
|
|||||
|
2021
Q4 | $2.13M | Sell |
|
|||||
|
2021
Q3 | $4.12M | Sell |
|
|||||
|
2021
Q2 | $11.7M | Sell |
|
|||||
|
2021
Q1 | $18.2M | Sell |
|
|||||
|
2020
Q4 | $14.4M | Sell |
|
|||||
|
2020
Q3 | $11.2M | Buy |
|
|||||
|
2020
Q2 | $7.01M | Buy |
|
|||||
|
2020
Q1 | $1.52M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $331K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $227K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $287K | Sell |
|
|||||
|
2017
Q4 | $9.63M | Sell |
|
|||||
|
2017
Q3 | $18.3M | Sell |
|
|||||
|
2017
Q2 | $14M | Sell |
|
|||||
|
2017
Q1 | $15.8M | Sell |
|
|||||
|
2016
Q4 | $17.5M | Buy |
|
|||||
|
2016
Q3 | $13.3M | Buy |
|
|||||
|
2016
Q2 | $14.3M | Buy |
|
|||||
|
2016
Q1 | $12.7M | Buy |
|
|||||
|
2015
Q4 | $14.2M | Buy |
|
|||||
|
2015
Q3 | $9.73M | Buy |
|
|||||
|
2015
Q2 | $8.77M | Buy |
|
|||||
|
2015
Q1 | $8.39M | Sell |
|
|||||
|
2014
Q4 | $8.08M | Sell |
|
|||||
|
2014
Q3 | $15.7M | Sell |
|
|||||
|
2014
Q2 | $19M | Sell |
|
|||||
|
2014
Q1 | $21.4M | Buy |
|
|||||
|
2013
Q4 | $7.96M | Buy |
|
|||||
|
2013
Q3 | $2.39M | Buy |
|
|||||
|
2013
Q2 | $207K | Buy |
|